Agree totally Steini.
This is a great move for us despite the short term pain. Doing what I can to add whilst the prices are low.
Our assets are attracting talent. We're not far off seeing the real progress for CF33 and onCARlytics just got a major boost. Plus, we have a CAR T that *could* make it to market as a first in class allo CAR T, in just a few short years. Let's face it, the Checkvacc trial is fast approaching its 2nd birthday so, in terms of timescales, the Azer-cel timeline looks good if they can stick to it.
As you say, it's a long way back for MSB unfortunately and there are plenty of other Bios having a hard time at the moment. And we've only strengthened our position.
New PD1-Vaxx trial soon, onCARlytics trial soon, CF33 updates and a number of key conference presentations that will provide further updates. World Lung Cancer conference in Singapore soon should give us some insight into the strength of the B Cell platforms, particularly PD1-Vaxx.
Am well into the forest, but not currently looking at the trees. Do steer clear of the mushrooms though. Plenty here on the forums too.
GLTAH.
Agree totally Steini. This is a great move for us despite the...
-
- There are more pages in this discussion • 65 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.1¢ |
Change
0.003(6.25%) |
Mkt cap ! $379.2M | |||
| Open | High | Low | Value | Volume |
| 4.9¢ | 5.5¢ | 4.8¢ | $4.098M | 80.11M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 1984777 | 5.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.2¢ | 450000 | 3 |
View Market Depth
| Last trade - 16.10pm 18/09/2024 (20 minute delay) ? |
| IMU (ASX) Chart |